Skip to content

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU

International Multicenter Study One Day Prevalence Observational Study for Delirium on ICU

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01278524
Acronym
IMPROVE-ICU
Enrollment
1002
Registered
2011-01-19
Start date
2011-01-31
Completion date
2011-01-31
Last updated
2013-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Keywords

Delirium, Analgosedation, ICU, Pain, Implementation

Brief summary

An anonymous international multicenter - clinical survey, one-day observational study.

Detailed description

Delirium is a serious complication in postoperative and critically ill patients and is independently associated with cognitive impairment at hospital discharge and with significantly higher 6-month mortality. Furthermore, ICU delirium is associated with more days requiring mechanically ventilation, longer ICU length of stay, and longer hospital length of stay. More recently a study by Pisani and co-workers' could show an association between days of delirium and mortality; - each additional day spent in delirium is associated with a 20% increased risk of prolonged hospitalization - translating to over 10 additional days - and a 10% increased risk of death.The reported prevalence of delirium in critically ill patients ranges widely from 11% to 87%. The aim of our study is to investigate the implementation rate of routine delirium assessment in European ICUs.

Interventions

None listed

Sponsors

European Society of Intensive Care Medicine
CollaboratorOTHER
Claudia Spies
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients staying in the ICU on the 25th of January (one-day prevalence study) No

Design outcomes

Primary

MeasureTime frame
Implementation rate of routine delirium assessment24 hours

Secondary

MeasureTime frame
Methodology of delirium assessment (e.g. type of score, frequency of evaluation)24 hours
Non-pharmacological treatment-/prevention strategies24 hours
Point prevalence of ICU delirium24 hours
Sedation practices (e.g. scales, daily sedation goals, SBT - spontaneous breathing trials, SAT - spontaneous awakening trials)24 hours
Analgesia regimes (e.g. scales)24 hours
Drugs used for delirium treatment24 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026